Physician profile
Maria Bernabe
NPI 1235138330
$4,284.39
in general payments reported to CMS, 2019-2025
40 companies · $539 in 2025
The $539 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $365 · 2021: $688 · 2022: $668 · 2023: $866 · 2024: $753 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,157.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $602.32 | 2022-2025 | |
| Amgen INC. | $524.04 | 2019-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $444.27 | 2019-2025 | Nucala, Arexvy, Shingrix |
| Novo Nordisk INC | $367.10 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $340.09 | 2019-2025 | Gardasil 9, Vaxneuvance, Verquvo |
| Astrazeneca Pharmaceuticals LP | $272.35 | 2019-2025 | Airsupra, Breztri |
| Lilly USA, LLC | $172.40 | 2020-2025 | Baqsimi, Jardiance |
| Abbott Laboratories | $139.20 | 2021-2024 | Freestyle Libre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.09 | 2021-2025 | Jardiance |
| Amarin Pharma, INC. | $97.26 | 2020-2022 | |
| Abbvie INC. | $95.71 | 2023-2024 | Vraylar |
| Takeda Pharmaceuticals U.S.A., INC. | $85.23 | 2019-2023 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $84.24 | 2025 | Caplyta |
| Shield Therapeutics INC | $69.86 | 2023-2024 | Accrufer |
| Pfizer INC. | $66.26 | 2020-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Bernabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.